P53 ubiquitination and proteasomal degradation

Methods in Molecular Biology

Volumn 962, Issue , 2013, Pages 63-73

  Love, Ian M ^a   Shi, Dingding ^b   Grossman, Steven R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

26S proteasome; MDM2; p53; Ubiquitin ligase; Ubiquitination

Indexed keywords

EID: 84871877992     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-236-0_5     Document Type: Article

References (14)

1. Pickart CM (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70:503-533
2. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM (2003) Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300(5617):342-344
3. Shi D, Pop MS, Kulikov R, Love IM, Kung AL, Grossman SR (2009) CBP and p300 are cyto-plasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci USA 106(38):16275-16280
4. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM (2000) Recognition of the polyubiquitin proteolytic signal. EMBO J 19(1):94-102
5. Behrends C, Harper JW (2011) Constructing and decoding unconventional ubiquitin chains. Nat Struct Mol Biol 5:520-528
6. de Oca M, Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378(6553):203-206
7. Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378(6553):206-208
8. Yu ZK, Geyer RK, Maki CG (2000) MDM2-dependent ubiquitination of nuclear and cyto-plasmic p53. Oncogene 19(51):5892-5897
9. Lai Z, Ferry KV, Diamond MA, Wee KE, Kim YB, Ma J, Yang T, Benfield PA, Copeland RA, Auger KR (2001) Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J Biol Chem 276(33):31357-31367
10. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429(6987):86-92
11. Le Cam L, Linares LK, Paul C, Julien E, Lacroix M, Hatchi E, Triboulet R, Bossis G, Shmueli A, Rodriguez MS, Coux O, Sardet C (2006) E4F1 is an atypical ubiquitin ligase that modulates p53 effector funct ions independently of degradation. Cell 127(4):775-788
12. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112(6):779-791
13. Love IM, Grossman SR (2012) It Takes 15 to Tango- Making Sense of the Many Ubiquitin Ligases of p53. Genes Can, in press
14. Linares LK, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O, Lacroix M, Le Cam L, Coux O, Benkirane M (2007) Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol 9(3):331-338